I am proud to present our new vision and tagline, which have been developed by the Leadership Forum, including more than 40 leaders from our global organization.
Marty J Duvall – CEO
Oncopeptides AB (publ) released its interim report for Q3 2020 on November 19, 2020.
Oncopeptides held a virtual Capital Markets Day for investors, analysts and journalists on November 30, 2020. The CMD was webcasted live and recorded, accessible through the link below.
We are science and data driven, innovative and curious, making decisions based on systematic and thorough analyses.
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you to the website of our US operations, Oncopeptides Inc. at www.oncopeptides-us.com